1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. XILIO THERAPEUTICS INC
Xilio Therapeutics Inc
XNAS: XLO
9.10 -0.10 (-1.09%)
18,964
XNAS Volume

XNAS 10 Jul, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Xilio Therapeutics Inc - XLO - stock price prediction, stock price target, analyst ratings from 1 analyst

Xilio Therapeutics Inc has a share price target of US$ 20, revenue growth forecast of -21.1%, for FY26, based on top 1 analyst call.